LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial. - Guan, Kai; Liu, Shuang; Feng, Yan; Li, Lisha; Zhu, Xiaoming; Bill, Nai‐Chau‐Sun; Ma, Haili; Yang, Jie; Han, Cuicui; Liu, Heng; Wei, Qingyu; Shi, Haiyun; et al. (Clinical & Translational Allergy, 2025)